Cargando…
Icare Home Tonometer: A Review of Characteristics and Clinical Utility
The Icare HOME (TA022, Icare Oy, Vanda, Finland) is rebound tonometer recently approved by the US Food and Drug Administration in March 2017 designed for self-measurement of intraocular pressure (IOP). IOP remains a major modifiable risk factor for glaucoma progression; however, IOP measurements typ...
Autores principales: | Liu, John, De Francesco, Ticiana, Schlenker, Matthew, Ahmed, Iqbal Ike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695605/ https://www.ncbi.nlm.nih.gov/pubmed/33262568 http://dx.doi.org/10.2147/OPTH.S284844 |
Ejemplares similares
-
Icare(®) rebound tonometers: review of their characteristics and ease of use
por: Nakakura, Shunsuke
Publicado: (2018) -
Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer
por: Gao, Feng, et al.
Publicado: (2017) -
Comprasion of ICare Rebound Tonometer and Goldmann Applanation Tonometer in High Myopia
por: Cagatay, Halil Huseyin, et al.
Publicado: (2014) -
Evaluation of rebound tonometer iCare IC200 as compared with IcarePRO and Goldmann applanation tonometer in patients with glaucoma
por: Nakakura, Shunsuke, et al.
Publicado: (2021) -
Agreement and repeatability of Icare ic100 tonometer
por: Jose, Judy, et al.
Publicado: (2020)